AtriCure reported a decrease in worldwide revenue by 30.7% year-over-year, with U.S. revenue decreasing by 28.6% and international revenue decreasing by 39.0%. The company experienced a trough in April followed by a rapid return in May and steady volumes through June. They did not provide 2020 financial guidance due to continued uncertainties from the impact of COVID-19.
Worldwide revenue decreased by 30.7% year-over-year to $40.8 million.
U.S. revenue decreased by 28.6% year-over-year to $33.7 million.
International revenue decreased by 39.0% year-over-year to $7.1 million.
Net loss per share was $0.20, compared to $0.11 for the second quarter of 2019.
AtriCure is not providing 2020 financial guidance due to the continued uncertainties from the impact of COVID-19.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance